4//SEC Filing
Davarpanah Nicole Negar 4
Accession 0001610618-25-000098
CIK 0001610618other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 7:37 PM ET
Size
5.0 KB
Accession
0001610618-25-000098
Insider Transaction Report
Form 4
Davarpanah Nicole Negar
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2025-12-10$219.60/sh−10,332$2,268,907→ 21,286 total
Footnotes (2)
- [F1]Shares withheld for taxes on RSU vesting.
- [F2]Includes 200 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on November 20, 2025.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0002067554
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 7:37 PM ET
- Size
- 5.0 KB